Newsroom

DUBLIN--(BUSINESS WIRE)--The "Australia Doors and Windows Market Size, Share Analysis and Forecast Report (2025-2034)" has been added to ResearchAndMarkets.com's offering. The Australia Doors and Windows Market, valued at AUD 5.73 billion in 2025, is anticipated to reach AUD 8.90 billion by 2034, driven by a consistent CAGR of 4.50%. This growth trajectory highlights significant opportunities and evolving trends within this competitive market. With segments based on material types such as metal...

FORT LEE, N.J.--(BUSINESS WIRE)--Cross River Bank (“Cross River”), a technology infrastructure provider that offers embedded financial solutions, today announced the expansion of its card program capabilities with the launch of its proprietary, in-house card processing engine. With this addition, Cross River joins a select group of financial institutions with complete ownership of the card technology stack — from issuing to processing. Aion Financial Technologies (“Aion”) has been selected as t...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Regions Financial Corp. announced its Board of Directors authorized the repurchase of up to $3.0 billion of the company’s common stock....

MUSCATINE, Iowa--(BUSINESS WIRE)--HNI Corporation announced today the completion of its acquisition of Steelcase Inc....

LONDON--(BUSINESS WIRE)--  ISIN Code. XS2777451787 Our Ref. MQ7344 ISSUE NAME. Commonwealth Bank of Australia Issue of USD 40,000,000.00 Capped Floating Rate Notes due 13 March 2029 Series 6577Tranche 1 MTN INTEREST PERIOD. 15/09/2025 TO 15/12/2025 VALUE DATE. 15/12/2025 INTEREST RATE. 5.06172 PCT NUM OF DAYS. 91 DAY BASIS. Actual/360 (A004) CURRENCY CODE. USD TOTAL INTEREST AMT. USD 511,796.13 POOL FACTOR. N/A...

瑞士楚格--(BUSINESS WIRE)--(美國商業資訊)-- 專注於生物相似藥研發和生產的一流生物製藥公司Polpharma Biologics欣然宣布，已與巴西企業Libbs Farmacêutica簽署一項具有里程碑意義的授權協議。透過這一策略性合作夥伴關係，Libbs Farmacêutica將獲得一款尖端自身免疫性疾病生物相似藥在快速成長的巴西市場的獨家商業化權利。 Polpharma Biologics將全權負責該生物相似藥的研發和生產工作。Libbs Farmacêutica則擁有該藥物在巴西的獨家商業化、行銷和經銷授權。此次合作開啟了令人振奮的新機會，也彰顯了兩家公司共同的承諾，即為病患提供創新且可及的治療方案。 Polpharma Biologics執行長Anjan Selz表示：「攜這款生物相似藥進軍巴西市場，對Polpharma Biologics而言是重要的一步，也體現了我們持續致力於在全球擴大高品質、可負擔生物治療藥物可及性的使命。Libbs Farmacêutica對巴西市場具有深入的瞭解，與該公司合作讓我們獲得了強大的商業專業知識。結合我們的研發和生產...

LONDON--(BUSINESS WIRE)--  ISIN Code. XS2643036218 Our Ref. MP7664 ISSUE NAME. Santander UK PLC Issue of GBP 1,100,000,000.00 Floating Rate Covered Bonds due June 2028 Series 81 Tranche 1 MTN INTEREST PERIOD. 12/09/2025 TO 12/12/2025 VALUE DATE. 12/12/2025 INTEREST RATE. 4.4877 PCT NUM OF DAYS. 91 DAY BASIS. ACTUAL/365 FIXED (A005) CURRENCY CODE. GBP TOTAL INTEREST AMT. GBP 12,307,363.56 POOL FACTOR. N/A...

瑞士楚格--(BUSINESS WIRE)--(美国商业资讯)-- 专注于生物类似药研发和生产的领先生物制药公司Polpharma Biologics欣然宣布，已与巴西企业Libbs Farmacêutica签署一项具有里程碑意义的授权协议。通过这一战略合作伙伴关系，Libbs Farmacêutica将获得一款尖端自身免疫性疾病生物类似药在快速增长的巴西市场的独家商业化权利。 Polpharma Biologics将全权负责该生物类似药的研发和生产工作。Libbs Farmacêutica则拥有该药物在巴西的独家商业化、营销和分销授权。此次合作开启了令人振奋的新机遇，也彰显了两家公司共同的承诺，即为患者提供创新且可及的治疗方案。 Polpharma Biologics首席执行官Anjan Selz表示：“携这款生物类似药进军巴西市场，对Polpharma Biologics而言是重要的一步，也体现了我们持续致力于在全球范围内扩大高质量、可负担生物治疗药物可及性的使命。Libbs Farmacêutica对巴西市场有着深入的了解，与该公司合作让我们获得了强大的商业专业知识。结合我们的研...

DOHA, Qatar--(BUSINESS WIRE)--Doha Debates della Qatar Foundation ha portato alla ribalta la pratica dei negoziati ad alto rischio con un episodio speciale in diretta del suo premiato podcast con Foreign Policy, The Negotiators, al Doha Forum, dopo il lancio della quinta stagione della serie di podcast il 1° dicembre. Organizzato in collaborazione con il partner speciale di The Negotiators per questa stagione, l'International Peace Institute (IPI), e con Foreign Policy, partner di produzione di...

DOHA, Qatar--(BUSINESS WIRE)--Doha Debates van de Qatar Foundation belichtte de praktijk van onderhandelingen waarbij er veel op het spel staat, met een speciale live-aflevering van de bekroonde podcast met Foreign Policy, The Negotiators, op het Doha Forum, na de lancering van het vijfde seizoen van de podcastserie op 1 december. De aflevering werd gemaakt in samenwerking met de speciale partner van The Negotiators voor dit seizoen, het International Peace Institute (IPI), en de langdurige pro...